The two new HIV drugs, Emtriva and Reyataz

The two new HIV drugs, Emtriva and Reyataz, will help simplify regimens...they're each given just ONCE a day.

Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir). It's well-tolerated and doesn't affect cytochrome P450 enzymes, so drug interactions aren't likely.

Emtriva is mostly excreted renally. Patients take it less often if they have a creatinine clearance < 50 mL/min.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote